Latest filing published 10 Nov 2025 for GoodRx Holdings, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Romin Nabiey discloses dealings in GoodRx Holdings, Inc. to SEC (Form 4). We count 40 filings; the first trade dates from 15 July 2022 and the latest from 8 March 2026.
Sales make up the whole of the open-market record (1 sale, €489k). Outside the open market, there are 39 option exercises.
On 9 March 2026 came the latest disclosure, an option exercise in GoodRx Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 35 declarations